Methylprednisolone (Medrol)- Multum
PLoS Genet 2013; 9: e1003190. OpenUrlCrossRefPubMedLi Y, Sheu CC, Ye Y, et al. Genetic variants Methylprednisolone (Medrol)- Multum risk of lung cancer in never smokers: a genome-wide association study. OpenUrlCrossRefPubMedWeb of ScienceAmos CI, Wu X, Broderick P, et al. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25. OpenUrlCrossRefPubMedWeb of ScienceThorgeirsson TE, Geller F, Sulem P, et al. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease.
OpenUrlCrossRefPubMedWeb of ScienceLan Q, Hsiung CA, Matsuo K, et al. Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia. OpenUrlCrossRefPubMedAhn MJ, Won HH, Lee J, et al. OpenUrlCrossRefPubMedLiu JZ, Tozzi Methylprednisolone (Medrol)- Multum, Waterworth DM, et al. Meta-analysis and imputation refines the association of 15q25 with smoking quantity.
OpenUrlCrossRefPubMedWeb of ScienceSaccone NL, Culverhouse RC, Schwantes-An TH, et al. Multiple independent loci at Methylprednisolone (Medrol)- Multum 15q25. PLoS Genet 2010; 6: e1001053. OpenUrlCrossRefPubMedFernandez-Garcia I, Ortiz-de-Solorzano C, Montuenga LM. Telomeres and telomerase in Methylprednisolone (Medrol)- Multum cancer. OpenUrlCrossRefPubMedZhao J, Gupta S, Seielstad M, et al. Pathway-based analysis using reduced gene subsets in genome-wide association studies.
BMC Bioinform 2011; 12: 17. OpenUrlCrossRefPubMedKhatri P, Sirota M, Butte AJ. Ten years of pathway analysis: current approaches and outstanding challenges.
PLoS Comput Biol 2012; 8: e1002375. OpenUrlCrossRefPubMedWang Y, McKay JD, Rafnar T, et al. Rare variants news australian large effect in BRCA2 and CHEK2 affect risk of lung cancer.
Tobacco as a Naproxen Sodium (Naprelan)- FDA of lung cancer: some reflections. OpenUrlFREE Full TextPeto R, Boreham J, Lopez AD, et al. Mortality from tobacco in developed countries: indirect estimation from national vital statistics. OpenUrlCrossRefPubMedWeb of ScienceIARC Methylprednisolone (Medrol)- Multum on the Evaluation of Carcinogenic Risks to Humans.
In: Tobacco smoke and involuntary smoking. Doll R, Peto Mike johnson, Boreham J, et al. BMJ 2004; 328: 1519. The Health Consequences of Smoking: 50 Years of Progress.
Further...